| The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial START Trialists' Group The lancet oncology 9 (4), 331-341, 2008 | 1095 | 2008 |
| Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified … MT Seymour, SR Brown, G Middleton, T Maughan, S Richman, S Gwyther, ... The lancet oncology 14 (8), 749-759, 2013 | 442 | 2013 |
| Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial L Lowry, P Smith, W Qian, S Falk, K Benstead, T Illidge, D Linch, ... Radiotherapy and Oncology 100 (1), 86-92, 2011 | 409 | 2011 |
| Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program F Cardoso, JMS Bartlett, L Slaets, CHM Van Deurzen, ... Annals of Oncology 29 (2), 405-417, 2018 | 362 | 2018 |
| 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ... The Lancet 393 (10191), 2599-2612, 2019 | 295 | 2019 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 187 | 2019 |
| Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial R Glynne-Jones, D Sebag-Montefiore, HM Meadows, D Cunningham, ... The lancet oncology 18 (3), 347-356, 2017 | 161 | 2017 |
| Pathological characterisation of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program MA Vermeulen, L Slaets, F Cardoso, SH Giordano, K Tryfonidis, ... European Journal of Cancer 82, 219-227, 2017 | 99 | 2017 |
| The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology JG Eriksen, AW Beavis, MA Coffey, JWH Leer, SM Magrini, K Benstead, ... Radiotherapy and Oncology 103 (1), 103-108, 2012 | 96 | 2012 |
| Radiation pneumonitis following treatment of non–small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART) P Jenkins, K D’Amico, K Benstead, S Elyan International Journal of Radiation Oncology* Biology* Physics 56 (2), 360-366, 2003 | 89 | 2003 |
| CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial M Gleeson, C Peckitt, YM To, L Edwards, J Oates, A Wotherspoon, ... The Lancet Haematology 5 (5), e190-e200, 2018 | 72 | 2018 |
| Recommended ESTRO core curriculum for radiation oncology/radiotherapy 4th edition K Benstead, PC Lara, D Andreopoulos, JE Bibault, A Dix, YG Eller, ... Radiotherapy and Oncology 141, 1-4, 2019 | 52 | 2019 |
| Abstract S6-05: Characterization of male breast cancer: First results of the EORTC10085/TBCRC/BIG/NABCG International Male BC Program F Cardoso, J Bartlett, L Slaets, C van Deurzen, E van Leewen-Stok, ... Cancer Research 75 (9_Supplement), S6-05-S6-05, 2015 | 43 | 2015 |
| Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program SC Doebar, L Slaets, F Cardoso, SH Giordano, JMS Bartlett, K Tryfonidis, ... Modern Pathology 30 (4), 509-518, 2017 | 41 | 2017 |
| Addition of panitumumab to irinotecan: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). MT Seymour, SR Brown, S Richman, GW Middleton, T Maughan, C Olivier, ... Journal of Clinical Oncology 29 (15_suppl), 3523-3523, 2011 | 41 | 2011 |
| Defining a leader role curriculum for radiation oncology: a global Delphi consensus study S Turner, M Seel, T Trotter, M Giuliani, K Benstead, JG Eriksen, ... Radiotherapy and Oncology 123 (2), 331-336, 2017 | 40 | 2017 |
| Stage III carcinoma of cervix. The importance of increasing age and extent of parametrial infiltration K Benstead, VJ Cowie, V Blair, RD Hunter Radiotherapy and Oncology 5 (4), 271-276, 1986 | 32 | 1986 |
| Multidisciplinary training of cancer specialists in Europe K Benstead, NS Turhal, N O'Higgins, L Wyld, M Czarnecka-Operacz, ... European Journal of Cancer 83, 1-8, 2017 | 31 | 2017 |
| A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’trial) for maintaining dose intensity of standard adjuvant chemotherapy for … RCF Leonard, JL Mansi, C Keerie, A Yellowlees, S Crawford, K Benstead, ... Annals of Oncology 26 (12), 2437-2441, 2015 | 30 | 2015 |
| Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in … CE Coles, CL Griffin, AM Kirby, JS Haviland, JC Titley, K Benstead, ... Cancer Research 79 (4_Supplement), GS4-05-GS4-05, 2019 | 28 | 2019 |
